BioLineRx Ltd. Increase Decrease In Cash And Cash Equivalents
BioLineRx Ltd. (BLRX) reported Increase Decrease In Cash And Cash Equivalents of -$7.74 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-23
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-12-31 | -$7.74M 20-F · filed 2026-03-23 | |
| 2025-06-30 | -$3.60M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $6.16M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $5.59M 6-K · filed 2025-08-14 | |
| 2023-12-31 | -$6.11M 20-F · filed 2026-03-23 | |
| 2023-06-30 | -$139.00K 6-K · filed 2024-08-15 | |
| 2022-12-31 | -$1.80M 20-F · filed 2025-03-31 | |
| 2022-06-30 | $1.57M 6-K · filed 2023-08-30 | |
| 2021-12-31 | -$4.05M 20-F · filed 2024-03-26 | |
| 2021-06-30 | $681.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | $11.33M 20-F · filed 2023-03-22 | |
| 2020-06-30 | $247.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | $1.78M 20-F · filed 2022-03-16 | |
| 2019-06-30 | $1.53M 6-K · filed 2020-08-06 | |
| 2018-12-31 | -$1.54M 20-F · filed 2021-02-23 | |
| 2018-06-30 | $532.00K 6-K · filed 2019-08-06 | |
| 2017-12-31 | $2.21M 20-F · filed 2020-03-12 | |
| 2017-06-30 | $4.26M 6-K · filed 2018-08-13 | |
| 2016-12-31 | -$3.13M 20-F · filed 2019-03-28 | |
| 2015-12-31 | -$279.00K 20-F · filed 2018-03-06 |